Stimulation of suicidal erythrocyte death by oridonin

Kashif Jilani1, Syed M Qadri, Christine Zelenak

  • 1Department of Physiology, University of Tuebingen, Gmelinstraße 5, D-72076 Tuebingen, Germany.

Insights

Oridonin, an anticancer agent, induces suicidal death in erythrocytes (red blood cells) by increasing calcium levels and ceramide formation. This novel finding reveals a new mechanism of oridonin

Area of Science:

  • Biochemistry
  • Cell Biology
  • Toxicology

Background:

  • Oridonin is recognized for its anticancer properties, primarily through inducing apoptosis in cancer cells.
  • Eryptosis, a form of suicidal cell death in erythrocytes, is characterized by cell shrinkage and phosphatidylserine exposure.
  • Eryptosis can be triggered by increased intracellular calcium, ATP depletion, and ceramide formation.

Purpose of the Study:

  • To investigate whether oridonin induces eryptosis in human erythrocytes.
  • To elucidate the specific mechanisms by which oridonin affects erythrocytes.

Main Methods:

  • Flow cytometry (FACS) was used to measure cell volume and phosphatidylserine exposure (annexin V binding).
  • Intracellular calcium levels were assessed using Fluo3-fluorescence.
  • Ceramide abundance was quantified using fluorescent antibodies.
  • ATP concentration was measured via a luciferin-luciferase assay.

Main Results:

  • Oridonin exposure (≥25μM for 48h) significantly increased intracellular calcium concentration and ceramide formation in erythrocytes.
  • Oridonin treatment led to cell shrinkage (decreased forward scatter) and phosphatidylserine exposure, indicative of eryptosis.
  • Oridonin did not significantly deplete ATP levels or cause substantial hemolysis.
  • The eryptotic effects of oridonin were partially reversible by removing extracellular calcium or adding amiloride.

Conclusions:

  • Oridonin triggers eryptosis, a novel suicidal death pathway in erythrocytes.
  • The mechanism involves calcium influx and ceramide generation, distinct from its known anticancer effects.
  • This study uncovers a previously unrecognized biological activity of oridonin.

Related Concept Videos

Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Necrosis01:16

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become anucleated and die, but their...
Erythropoiesis01:14

Erythropoiesis

Red blood cells  (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia, and...
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...